4.8 Editorial Material

A step forward for LRRK2 inhibitors in Parkinson's disease

期刊

SCIENCE TRANSLATIONAL MEDICINE
卷 14, 期 648, 页码 -

出版社

AMER ASSOC ADVANCEMENT SCIENCE
DOI: 10.1126/scitranslmed.abq7374

关键词

-

资金

  1. Aligning Science Across Parkinson's through the Michael J. Fox Foundation for Parkinson's Research [ASAP-000478]

向作者/读者索取更多资源

A phase 1 clinical trial for kinase inhibitors targeting LRRK2 lays the groundwork for evaluating the effectiveness of LRRK2 kinase inhibitors in Parkinson's disease.
A phase 1 clinical trial for kinase inhibitors targeting LRRK2 provides the foundation for testing the efficacy of LRRK2 kinase inhibitors in Parkinson's disease.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据